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T he capacity of mast cell products to mediate T - cell 
adhesion to fibroblasts was explored using hetero-
typic coculture systems or by exposing fibroblasts to 
mast-ceIl-conditioned media (MCCM), prepared by 
de granulating mast cells with calcium ionophore . 
Experimental results indicated that fibroblasts ex-
posed to MCCM for 24 h bound fivefold more T cells 
than control fibroblasts . Binding was inhibited with 
intercellular adhesion molecule- l (ICAM-l) or vascu-
lar cell adhesion molecule-l (VCAM- l) neutralizing 
I antibodies. Enzyme-linked immunosorbent assay and 
flu orescence- activated cell sorter analysis revealed 
that fibroblasts exposed to MCCM markedly in-
creased ICAM-l and VCAM-l surface expression by 4 
h, -w-ith levels maximal at 16 h and returning toward 
baseline by 48 h . A dose-dependent response of 
ICAM-l and VCAM- l expression was noted using 
serial dilutions of MCCM or by altering the ratio of 
de granulated mast cells cocultured with fibroblasts . 
R e cently , a ple tho ra of studies h ave emerged that de~i c t t.he m.o l.e.cuhU'. m ech an.ism s un.de rl yiJ1~ the e lmgratJon of clrcula t lllg ce ll s mto p enpheral tlssue sites during inAammation [1-3]. M ost investigators h ave focused o n events earl y in the process of 
leukocyte recruitment, thus n ot addressing the qu estion of how 
leukocyte accumulatio n is su sta ine d in the extravascular space at a 
site of inAammation. Endoth e lial cells Lining the microvasculatu re 
f are c ritical to earl y events .by express ing adhcsiv~ m o lecu les in 
response to mAamm atory SIgnal s. W c ha ve preVIOusly d e mon-
strated [4] that mast ce ll s activate microvascular endoth elia l ce lls, 
leading to enhanced expressio n of inte rcellular adhes ion m o le-
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Similar results were obtained using human fibroblasts 
derived from the derm.is, synoviun'l, and lung, al-
though lung fibroblasts were generally less respon-
sive. Northern analysis confirmed that MCCM regu-
lated ICAM-l and VCAM-l expression at the mRNA 
level. In summary, mast cell products stimulated 
fibroblast surface expression, steady-state mRNA 
levels, and functional expression of ICAM-l and 
VCAM-1. Experimental data suggest that mast-cell-
derived tumor necrosis factor- a may be in large part 
responsible for these observations, although further 
studies using hun'lan mast cells will be required. 
Using a skin-equivalent organotypic co culture model 
with fibroblasts adl1'lixed with mast cells, we observed 
increased ICAM-l expression in both keratinocytes 
and fibroblasts after activation of the mast cells. K ey 
words: //last cell degl'alllliatioll/adltesioll //IoleCllie/ly"'pho-
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c ule-l (TCAM-l) and vascular cell adh esion m o lecule-l (V CAM-
1) . T h ese events may be operative when m ast cells contact an 
allergen and initiate an inflammatory reaction . We n ow extcn d 
these o bservations to pro b e how m as t cells mig ht sllsta in an 
inA ammatory reac tio n , as in a late-ph ase all c rgic response . A 
m echanism by w hich thi s mig h t occur is up-regulation of the 
adh esive prope rti es of fibrobla sts in extravascular sites . T here fore, 
w e studie d the capacity o f mast cell products to induce both 
lymph ocyte adhe rence to fibroblasts and ICAM-l and V CAM-l 
expressio n . O ur d ata show that mast cells m ediate lymphocyte 
attac hment to fibroblasts b y up- regulating TCAM-l and VCAM-l 
o n the sllrface of fi broblasts. 
MATERI ALS AND METHODS 
Materials Oulbecco's modified Eagle's medium (DMEM), feta l bovine 
serum (FBS) . penicillin , streptomycin . and Fungizone werc purchased fi'om 
Gibco Laboratories (Grand Island, NY). Percoll , calcium ionophore 
A23187, hi stamine, and hcparin Were purchased from Sigma (St. Louis. 
MO). Mousc monoclonal antibody (MoAb) spccific for VCAM-1 was 
obtained from Genzymc (Cambridge , MA). IUU / 1 MoAb. which recog-
nizes ICAM-I , was generously provided by Dr. R obert Rothlein at 
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Boehringer Mannheim (Ridgefield. CT). No cross-reactiv ity ex ists in the 
recognition of these Illo lecu les by these MoAb reagents. H orseradish 
peroxidase-conjugated goat anti-mouse IgG and fluorescein isothiocyanate 
(FITC)-conjugated sheep anti-mouse IgG were obtained from Cappel 
(Durham . NC); contro l mo use ascites fl uid was from Sigma; biotinylated 
horse anti-mo use IgG and streptavidin-conjugatcd horserad ish peroxidase 
were from Vector (Burlingame. CAl. Polyclona l rabbit anti-Illo use tumor 
necrosis factor-a (TNF-a) neutra li zing antibody. murine T NF-a. intcrl cu-
kin (IL)-l/3. IL-4, and human T-cell emichment co lumn werc purchased 
from R &D System s (Minneapo lis, MN) . Hamster monoclona l B122 anti-
murine IL-l/3 was kind ly providcd by Dr. David C haplin at Howard 
Hughes Medical Institute (St. Louis. MO). 
T he ability of antibody Bl22 to neutralize the bio logic activity of murine 
rlL-l/3 has been verified using the Dl0 costimulation assay 1.5]. The abili ty 
of neutrali zing antibody to inh.i bit rTNF-a-induced IC AM-l and VCA M-l 
expression o n fibroblasts was tested. The antibody was capable ofinh.ibiting 
93% to 95'X, of rTNF-a-induced ICAM- l and VCAM-l expression on 
human derma l fibrob lasts. if concentrations of rTNF-a were 10 ng/ml or 
less (data not shown). All the mast cell re leasates used for these experiments 
contained less than 10 ng/ml of TNF-a, as determined by standard 
cytotoxicity bioassay using L929 ce lls [6]. 
Cell Culture Normal human dermal fibrobla sts isolated from adult 
dermis were obta ined from the Nationa l Insti tute on Aging , Aging Cell 
C ulture R epository, Coriel Insti tu te for Medica l Research (Camden, NJ), 
designated AG05838A and AG04 145. Al l fibroblasts were cu ltured in 
DMEM with 10% heat-inactivated FBS, 100 U/ml penicillin. 100 j.l.g/ml 
streptomycin, and 250 ng/ml FUllgizone (Gibco) . DMEM with 0 .1 % 
high-puri ty bovine serum albumin (medium A) was used in the experiments 
described below . 
In som e experiments, normal human adult lung fibroblasts and synovia 
fib roblasts were also used for comparing the resu lts of fibrob lasts from 
different organ tissues. Human lung fibroblasts. designated AG02603. were 
obtained fi·om the same source as above. These cells were also cul tured in 
DMEM with 10% heat-inactivated FBS, 100 U / ml penicillin, 100 j.l.g/ml 
streptomycin, and 250 ng/ml Fungizone (Gibco). Human synovial fIbro-
blas ts were isolated from normal synovium of adu lt patients undergoing 
joint surgery as a result of acciden ta l trauma. Human synovial fibrob lasts 
we re cultured in RPMI medium with lO'Yo FBS, 100 U / ml penicillin, 100 
j.l.g/ml streptomycin , and 250 ng/ml Fungizone (Gibco). 
Preparation of Mast-Cell-Conditioned Media (MCCM) Bone-mar-
row-derived IL-3-independent murinc mast cell s (CI . MCIC57 . 1; kindly 
supplicd by Dr. S. Ga lli , Boston, MA) [6J were maintained in DMEM with 
10% FBS. 2 mM L-glutamine (Gibco), and 500 mM 2-hydroxyethylmer-
captan (Sigma). To prepare mast cell rel easates, mast cells in fresh culture 
medium were degran ulated by exposure to the mast cell secretagogue 
calcium io nophore A23187 . O ptimal stimulation and rel ease were acquired 
by incubating mast cclls (3 X 10"/ml) with 500 ng/ml A23187 for 6 h at 
37°C. Mast ce ll supernatants were aliq uoted and stored at -70°C to be used 
for filture experiments. R.at peritoneal mast cell s were also used for 
preparing mast cell releasates of a connective tissue phenotype. Rat 
peritoneal mast ce ll s were fres hl y isolated by a Perco ll dens ity gradient 
technique essentially as described by Enerbiick and Svensson [7]. Histamine 
sec re tion was quantitated by a do uble radioenzymatic assay [8] to mon.itor 
1113St ccl1 degranulation . 
Preparation of Human Lymphocytes Peripheral blood mononuclea r 
ce ll s were obtained from normal donors of bo th sexes and prepared by 
centrifugation o n density gradients of Ficoll-Hypaque (Pharmacia). Cell s 
were washed in supplemented Eagle's minimal essential medium (Gibco) 
and then passed over a T-cell enri chmcnt column (R&D Systems). The 
resulting cell population consisted of highly enri ched T cell s of93% to 95% 
purity, with contaminating cells consi sting of natura l ki ll er cell s, as con-
firmed by surface marker staining and fluorescence-activated cell sorter 
(FACS) analys is. T hese preparations were used as the source of cells for 
adherence studies, as descri bed below. 
Adhesion Protein Enzyme-Linked Immunosorbent Assay (ELISA) 
Confluent cultures of fibrob lasts in 96-well plates (Falcon) were incubated 
at 37°C for specified periods of time with varying concentrations of either 
MCCM or intact m ast cell s exposed to the degranulating agent, A23187. 
Contro ls consisted of trcatl11cnt \vith calciulTI ionophorc alone or culture 
medium alone. Cell monolayers were washed twice with serum-free cul ture 
medium conta ining 0.1 % bovine serum albumin (medium A) and incubated 
with MoAbs (2 j.l.g/ml) to ICAM-l o r VCAM-l di lu ted in mcdium A for 60 
min at 37°C. T he cells were then washed thTec times and incubated for 30 
111in at rOOlll tenlperature \V'ith ho rseradish peroxidase-conjugated goat 
anti-mouse IgG antibody diluted in medium A. T he well s were aga in 
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washcd, and the binding of antibodies was assessed by the addition to each 
well of 1 00 j.l.l of tetramethylbenzidine peroxidase substrate (Kirkcgaard & 
Perry Labs. Ga ithcrsburg, MD). After the reaction was stopped by the 
addition of 100 j.l.l of 0.08 N H2S04 , absorbance was measured at 450 nm 
o n an ELI SA reader (ThermoM ax; Mo lecular Devices, Menlo Park. CAl 
interfaced w ith Mac intosh software . Controls consisted of an irre levant 
isotype-matched monoclona l antibody (MOPC. IgG l: Sigma) alld deletion 
of the primary MoAbs. All ELI SA data expressed rep resent the mean of 
several experiments, each perfo rmed in tr ipl icate. Statistica ll y sign ificant 
in creases in expressio n over baseline were analyzed by ana lys is of va ri allce. 
FACS Analysis of Adhesion Molecules Fibro blasts were grown to 
confluence in T - 75 flasks (Falcon) and thell stimulated w ith MCCM for 
spec ific time periods. Control s consisted of treatmcnt w ith calcium iono-
phore alo ne or cul ture m edium alo ne. Ce ll s were harvested with cell 
dissociation buller (Gibco), washed twice in m edium A. and incubated for 
10 m in at 37°C to allow recovery. Cell s at a density ofl0"/ml were then 
incubated with primary M oA bs fo r 60 min at 4°C . Irre lcvant pooled mouse 
IgG (Sigma) was used as a control. After three was hcs w ith co ld medium A. 
FITC-conjugated sheep anti-mo use IgG (6 j.l.g/ml) was added fo r another 
60-min incubation at 4°C. The cell s were washed exhaustively w ith cold 
phosphate- buffered saline (PBS) and resuspended in PBS to yield 2 X 106 
cells/ml. T he cell surface cxpression was quantitated by fl ow cytometry 
performed with a FACStar Plus ce ll sorter (Becton D ickinson Immllnocy-
tometry Systems, San J ose, CAl, and the da ta we re ana lyzed using LYSYS 
II software on an HP 340 computer worksta tion (Hewlett Packard. Fort 
Collins , CO). 
T-cell Adhesion Assay T he assay was perfo rmed esscntially as described 
by Piela-Smith et nl [9]. Briefl y, confluent fib roblasts in 96- well plates were 
stimulated with MCCM, as described above. The cell s were then washed 
with complete m edium prewarmed to 37"C, and 100 p.1 of purified 
T -Iymphocyte suspension (4-5 X 10"/ml) was added . After a coincubation. 
period of 1 h at 37°C to allow the T lymphocytes to bind to fibrob lasts, 
nonadherent T ce ll s were removed by gentl e washing of the monolayers 
w ith m edium A, prewarmed to 37°C. In some instances, neutralizing 
MoAbs to ICAM-l or VCAM-l were added to fi broblast cultures for 60 
min at 37"C before the addition of T cell s. 
Ad herent T ce ll s were quantitated by microscopic examination after cell 
monolayers were air dried and sta ined with 1 % methylene blue. Four 
random fie lds in each well were counted using an ocular grid . Adhesion is 
expressed as the number of adherent T cells per grid . R.esul ts are expressed 
as the mean of tripli cate well s. 
Northern Hybridization The VCAM-l cDNA (kindly provided by Dr. 
C.M. Ballan tyne, H ouston , TX) was isolated as approximately a 1000 -
base-pair Psl l fragment and directl y labeled in I % low-mel t agarose by 
ra ndom hexamcr priming using J2 p-dCTP (DuPont NEN, Boston, MA) 
[10J. T he ICAM-l ml~A probe was pG4 Hl.lms-plasmid (kindly pro-
vided by Dr. T. Springer. Ccnter for Dlood R.esearch , Boston. MA) [5]. A 
Kpll l-Sn/l 1.5- kb fragment inse rt was labeled by the rando m primer kit 
(DuPont NEN) . Specific activity ranged fI·om 1 X 10" to 1 X 10" cpm/j.l.g 
DNA. Confluent fibrob lasts were treated with MCCM or media alone for 
the period of time indica ted. Tota l cellular I~A was extracted using 
guanidinium isotluocyanatc and pheno l-chloroform-isoamyl alcohol [1 1]. 
Equa l amounts of total I~A (20 j.l.g) from each sample wcre subjected to 
electrophoresis on a 1.2% aga rose- fonnaldebyde gel and transferred to 
nitrocellulose [1 2]. T he m embrane was prchybridized fo r 4 h at 42°C (50% 
formam ide, 5 X Dcnhardts . 0.2% sodium dodecylsulfate, 50 j.l.g/ ml boiled 
salmon sperm DNA,S X standard sal inc citrate. 50 mM HE PES, 5 mM 
ethylenediaminetetraacetic acid , and 10 j.l.g/ml poly-A). Overnight hybrid-
ization was performed at 42°C in the same solu tion containing radiolabeled 
pro be. T he m embrane was washed to a fina l stringency condition of 0.1 X 
standard sa line citrate/O.l % sodium dodecylsul f.1te at 68°C for 1 h and 
exposed to Kodak X- O mat fi lm at - 70°C with an intensirying screen fo r 24 
to 48 h . W hen appropriate. the nitroccllulose fi lters were stripped by 
boiling , and the adequacy of stripping was confirmed by overnight autora-
diography at - 70°C before rehybridization with the glycera ldehyde-3-
phospha te dehydrogenase (GAPDH) cD NA probe. Densitometry was 
performed using the IMAGE software sys tem. 
Organotypic Skin-Equivalent Culture Model Human foreskin kera-
tinocytes were cu ltured on human dermal foreskin fib roblas ts in organo-
typic coculture to generate skin equi valents, as described previously [13]. 
Mast cells were mixed with fibroblasts in a ratio of 1:4 in co llagen type I 
111atrix (Organogenes is. Canto n, MA) to fornl a c0l11pos itc cul ture in 
co ll agen. Keratinocytes, seeded on thi s dermal equivalent , stratified and 
formed a full y differcntiarcd epithelial layer. Contro ls consisted of fi bro-
blasts in coll agen in thc absence of mast cell s, treated otherwise in an 
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Figure 1. T-cell adhcrcncc to mast-ccll-conditioncd fibroblasts. 
T -cell adherence to unstimulated (Ctrl) human dermal fibrob lasts and 
fibroblasts stimulated with MCCM (1 :1 0) for indicated time intervals (Itft). 
The effect of stimulation for 24 h with incremental concentrations of 
MCCM is al so shown (right). Data represcnt the mean :!: SEM of two 
experunents performcd in triplicate we lls. 
ident:ica l manncr including exposure to mast cell secretagogue A23187. The 
organotypic modcl was cul tured for 7 d at the air interface to allow 
completc stratification and differcntiation of surface keratinocytes, aftcr 
which calcium ionophore A23187 was added to the media. After overnight 
incuba t:ion , the organotypic cultures were snap fi'ozcn in liquid nitrogen in 
emb edding compound (TBS, Durham, NC) and stored at -70°C. 
Irntnunopcroxidasc Studies of ICAM-l Expression in the Skin-
Equivalcnt Model Spccimcns were proccssed by prcparing 7-/.i-m cryo-
sta t sections, which wcre then air dricd and fixed in acetone beforc 
rehydration in PBS . Aftcr 60 min preincubation with 5% horsc sc rum, tissuc 
sect:ion s were reacted with primary MoAbs dirccted aga inst ICAM-l (kindly 
supplied by Robert Rothlein. Bochringer lngclheim, Ridgefield, CT) or 
VCAM-l (R&D) at room temperature for 60 min. Aftcr three washes with 
PBS p lus 0. 1 'X, bovine scrum albumin, biotinylated horsc anti-mouse IgG 
(1 5 ,....g/ml) was added for 30 min . T hc slides wcre again was hed beforc 
I incubar.ion with strcptavidin conjugated to alkaline phosphatase (Vector) for 
30 min. T hc specimens were visuali zed after the addition of fast red 
subSITatc (B ioGenics. Sa n Ramon, CAl. The sections were thcn coun tc r-
stained with hematox ylin before dehydration and mounting. Control 
experuncnts delcting the primary MoAbs wcre performed routinely to allow 
assessment ofcndogc ll o ll s avidin-binding activ ity and no nspecifi c reactivity . 
R.ESULTS 
MCCM Induces Lymphocyte Attachment to Human Der-
mal Fibroblasts A cell adh esion assay was perform ed to de ter-
mille the functiona l consequences of exposure of human dermal 
fi broblasts to M CCM . To in vestigate the effect of mast cell 
produc ts o n fibro blast cell adhesiven ess, we added M CCM (previ-
ously p repared b y dcgranulating mast cells with calcium ionophore) 
to confl uent fi bro bl asts in culture. After defined time interva ls, the 
fibro blasts were washed with fresh culture m edium, and purified 
human T cells were incubated w ith human derm al fibroblasts. After 
an add iti ona l hour, the nonadherent T cells were removed by 
washing. As sh own in Fig 1 , exposure of human dermal fibroblasts 
to MCCM resu lted in increased lymphocyte adherence, with 
max:irn.a l va lues observed by 24 h . MCCM induced approximately 
fivefold increases in T-cel l adh eren ce to human dermal fibrob lasts. 
To assess the contributio n o f ICAM-1 and VCAM-l to T - cell 
adhesion after M CCM stimulatio n of fibrob lasts, we used MoAbs 
to ICAM- l and VCAM-l for b locking experiments. M CCM-
treated human de rmal fibroblasts w ere pre incubated with MoAbs 
to either ICAM-l o r VCAM-l at 37°C for 60 min before addition 
of T cells. T - cell adhesion to hum an de rmal fi brobl asts could be 
markedly diminished by antibody to e ither ICAM-l o r VCAM- l , 
and a combination of these antibodies yie lded furth e r inhibition 
(Fig 2). Contro l isotype-matched m onoclo nal antibodies had no 
effect o n the T - cell binding . M CCM prepared by culturing the mast 
cell s in the absence of any mast cell secre tagogue had minimal e ffect 
on stimulating T - ce ll binding (Fig 2). Essentially all the cultured 
fi broblasts bo und numerous T ce lls to the surfa ce after exposure to 
MCCM, as shown in Fig 3 . 
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Figure 2. Inhibition of T-cell adhesion to human dermal fibro-
blasts stimulatcd with MCCM. T cells were added to unstimulated (Ctrl) 
human dermal fibrob lasts or fibroblasts stimulated for 24 h with MCCM 
(1:10) as shown. T he inh.ibition ofT-cell adhercnce is indicated, following 
incubation of MCCM-stimulated human dermal fibrobla sts with blocking 
antibody (Ab) to ICAM-l or VCAM-l before the addition ofT cells. T he 
efFect of isotype-matched control MoAb on T-cell binding is shown. Data 
rcpresent thc mean :!: SEM of two experiments performed in triplicate. 
Cocultured Mast Cells and Fibroblasts or MCCM Increased 
Fibroblast Expression of ICAM-l and VCAM-1 Conflu en t 
human derm al fibrob lasts o n 96-well mi crotiter plates w ere cocul -
tured with m ast cells, which subseq uently were degranulated by th e 
addition of calcium ionoph ore (500 ng/ ml). The induction of 
ICAM-l and VCAM-l was determined at 16 h by ELISA. Elevated 
cell surface expression of ICAM-l and V CA M-1 ad hesio n proteins 
was observed on human dermal fibroblasts cocultured with de-
g ranula ted mast cells (Fig 4). Calcium ionophore alone had n o 
direct effect on human derm al fIbrobla sts. A dose-dependent 
response was noted by vat-yin g the ratio of m ast cells to fibrobla sts 
in coculture. At a ratio as low as 1:1000 m as t cell s to fibrobla sts, 
ICAM-1 and VCAM-l induction was noted, although statistica lly 
significant increased expression (p < 0.05) was reach ed at ratios of 
1: 1 00 and high er (Fig 4) . M ast cells cocultured with hum an dermal 
fibrob lasts in the absen ce of the calcium ionopho re fa il ed to induce 
adhesion m o lecule express ion. Furth ermore , mast cells themse lves 
(in the absen ce of fibroblasts) demonstrated no surface sta ining fo r 
human ICAM-l o r VCAM-l , using these MoAbs (d ata n ot sh own) . 
A time-course experim ent of adh esio n m olecule expression after 
exposure to M CCM was performed, using ELISA to m onitor the 
cell surface expression . Maximal expression was noted between 16 
and 24 h , with approximate ly 120% and 460% increases (p < 0.05) 
of ICAM- l and VCAM-l, respectively, over baseHne levels o n 
human dermal fib roblasts (Fig SA). T he expression ofVCAM-l in 
parti cul ar then declined at 48 h but was' still maintained above the 
control level (p < 0.05) (Fig 5). Similar kine tic curves were 
observed using human syn ovial fibrob lasts , with approximately 
S5'!!o and 4501Yc, maximal increases (p < 0.05) of IC AM-l ;lIld 
VCAM - 1, respectively (Fig SB) . T he induction ofICAM-l (41 %) 
and VCAM-l (85%) on human lung fi broblasts by MCCM was less 
prominent (p > 0.05) as compared w ith de rmal or syn ovia l 
fibrob lasts (Fig SC) . T he m ast cell secretagogu e A23187 h ad n o 
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F ig u re 3. T -cell a dhesion to cultured fibrobla sts treated with MCCM. T ce ll s were allo wed to attach to unstimulated human dermal fi broblasts (A) 
or fibro blasts after exposure to MCCM (1:10) fo r 24 b (B) and then washed. O nl y adherent T cell s arc o bserved (a rrolll) . T he ad hesion ofT ce ll s to confluclH 
human de rmal fi broblasts was inhibi ted by the addi tion of an tibody to either ICA M- l (C) or VCA M-1 (D). Bar. 360 /.tln . 
direct effect on th e expressio n of these adhesion m o lecules (data not 
shown). T he kine tics and dose dependency of M CCM-induced 
en.hancement of T-cell adhesion were therefo re similar to the cell 
surface express io n of adhesion prote ins in human dermal fibro-
bl as ts, with significant increases seen as early as 4 h (p < 0 .05) and 
declining responses by 48 h (Figs 1, 5) . Con tro l isotype-matched 
M oAbs revealed background bindin g similar to th at of unstimulated 
fi broblas ts (da ta no t shown). 
T h e inductio n of ICAM-1 and V CA M-1 occurred in a concen-
tration-dependent mann er, as determin ed by the additio n of step-
wise dilutio ns of MCCM to fibrobla sts (Figs 4, 5). A trend of 
increase was detected w h en M CCM w as added to hum an dermal 
fibroblasts at a con centration as low as 1:100, alth ough a significan t 
in crease was observed at 1: 20 (p < 0.05). T h.i s dose dependency 
was no t as evident on hum an lung fibroblasts as on dermal and 
synovial fibrobl asts. Under these experimental condi tion s, consti-
tutiv e expression of lCA M-l w as higher than that o f VCAM-l , 
especiall y o n human de rmal fibro blasts and human syno via l fibro-
bl asts. 
F ACS Analysis of Mast-Cell-Induced ICAM-1 and VCAM-1 
Expression on Fibroblasts T he effect of M CCM on the cell 
surface express ion of lCAM-l and V C AM-l 0 11 human dermal 
fibrobl asts was also studied by FACS assay (Fig 6) . Confirming the 
ELISA studies, human dermal fibro bl as ts constituti ve ly expressed 
lCAM- l (Fig 6B) . At 24 h, incuba tion w ith M CCM resul ted in a 
10- fo ld increase of IC AM-l expression and a six fo ld increase of 
VCAM-1 express ion on human dermal fIbro blasts (Fig 6q. 
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F igure 4 . Co culture of human derlllal fibroblasts with deg r a l1u-
late d mast celJs induced ICAM-l and VCAM-l expression in 
hnman dermal fibroblasts. T he Ilumber of mast ce ll s (M C) ilddcd to 
confluent human dermal fibroblasts (H DFb) was varied to provide c!rector: 
target cell ratios as depicted . Mast ce ll s were then dcgran lll ated using 
ca lcium ionophorc (500 ng/ml) . ICA M-1 and VCA M- 1 expression at 16 It 
was measured by ELISA. Diltil represent the mean :!: SEM of two 
experimen ts performed in tr ipli cate. 
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Figure 5. MCCM-induced tilne course and dose response of adhe-
sion molecule expression on fibroblasts. Cell surf.,ce exprcssion of 
JCAM-l and VCAM- l on cultured human dcrmal fibrobl asts (A), human 
synovial fibroblasts (B) , and human lung fibroblasts (C) was determined by 
ELISA. Fibroblasts werc grown to conAucncc on 96-wcll ti ssue culture 
plates and thcn stimulawd for the above indicated intervals with MCCM at 
the dilution of 1:1 0 or with incrcmental amounts of MCCM for 24 h. T hc 
daca represent the mcan of four cxperimcnts in human dermal fibrob lasts 
(A ) and the mean of three cxpcrimcnts in human sY I~ovial : broblasts (B) 
and human lung fibrob lasts (C). all performcd m trlp lIcatc (- SEM) . Ctr! . 
control. 
Determination of the Active Corn.ponent of MCCM In an 
attern pt to determine which of the potential factors secreted by 
I mast ce lls was respon sibl e for the effects o bserved on fibrob las ts , we 
add ed several well-characte rized m ast cell products direcrly to 
culcured human dermal fibrob lasts. ICAM-1 and VCAM-l were 
then measured at 24 h by ELISA. T he results indicated that 
histamin e (Fig 7) and heparin (data not shown) h ad no significant 
effect o n adhes io n m o lecule express ion . R ecombinan t IL-l/3 and 
TNF- a gave the expected resu lts of lCA M-1 up-regulation (p < 
0.05); they caused o nly slight, and sta ti stically n onsignificant, 
up-regulation of VCAM-l compared w ith baseline (Fig 7) . IL-4 
had no significant effect o n ICAM- l; however, it induced promi-
nent VCAM-1 express ion (p < 0.05) o n human dermal fibrob lasts . 
To determin e the responsible cytokine within the crude MCCM 
that s timulated the adhesion mol ecule expression, we pretreated 
MeeM with n eutra liz ing antibodies to T NF-a, IL-l {3 , or IL-4 and 
meas ured the efFect on human dermal fibrob lasts. T NF-a neutral-
izing a ntibody was capable of inhibiting 85% of the ICAM-l but 
only 53% of the VCAM-1 response (Fig 8) . Incubation of MCCM 
with antibodies to TNF-a and IL-l /3 toge ther o r th e combin ation 
of antibo dies to TNF- a and IL- 4 was no m ore effective than T NF-a 
neutralizi.n g antibody alone. Neutraliz ing antibody to IL-l {3 alon e 
gave 40% and 201:10 inhibition , respective ly, of ICAM-l and 
VCAM-l induction. Neutralizing antibody to IL-4 alon e inhibited 
20% of lCAM-1 and showed n o inhibiti on of VCAM- 1 induction . 
Hence, it appears that T N F- a is largely responsibl e for increased 
ICAM- l expression, but this m ast-cell-derived cytokine is only 
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Figure 6. Flow cytometric analysis of ICAM-l and VCAM-l ex-
pression on hnman dermal fibroblasts induced by MCCM. ConAuent 
human dermal fibro blasts were stimulated for 24 h with MCCM (1 , I 0). 
With;n each graph, the adhesion molccules as depicted were quantitated 
under identica l conditions in the abscncc ofMCCM (B) and the prcsence of 
MCCM (C). 
partially responsible for VCAM-1 indu ction . In either case, studies 
usi.ng human mast-cell-derived cytokines w ill be required to gather 
more information con cerning endothelial ce ll activators relevant to 
inflamm ation of th e human m icrovasculature. 
MCCM Increases ICAM-1 a nd VCAM-l mRNA in Human 
Fibroblasts N orthe rn blot an alys is was performed to examine 
the efFect of MCCM on ICAM-l and VCAM-l mR.NA expression 
in cul tured human dermal fib ro blasts. Confluent human dermal 
fibroblasts were treated w ith MCCM for 1, 4, and 24 h or with 
contro l media containing calcium ionopho re alone. VCAM-l 
mRNA was undetectable and ICAM-J mRNA was barely detect-
able in the fibroblasts cultured in the contro l m edia (Fig 9) . In 
contrast, incubation w ith MCCM increased the steady-state levels 
of ICAM-l and VCAM-l mRNA expression by 1 h . T he maximal 
accumulation was observed at 4 h and decreased toward baseline by 
24 h (Fig 9) . No signi ficant change in mRNA levels for GAPDH 
ICAM· I 
c:J l"NF" CI TNF" 
mil -III 
am IL-4 
" CAM · ! 
Cytold l1 tSlng/ml) 
Figure 7 . Induction of ICAM-l and VCAM-l cell surface expres-
sion on hunlan dermal fibroblasts by mast cell products . The 
products wcrc added to thc conAucnt fibroblasts in the concentrations as 
dcpicted fo r 24 h. The results reprcsent tlIe mean :!: SEM of thrce 
cxperiments performed in triplicate. 
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Figure 8. Inhibition of MCCM regulatory effect on ICAM-l and 
VCAM-l expression. The adhesion molecule expression on human 
dermal fibrob lasts was determined by ELISA at 24 h after preincubation of 
neutralizing antibodies (10 ng/ ml) to MCCM as indicated. Data represent 
the mean :±: SEM of two experiments performed in triplicate wells . Ctrl, 
control. 
control probe was found after MCCM treatment (Fig 9, bottolll) , 
confirming that the differences noted above were not due to 
rnRNA loading, transfer, or nonspecific stimulation. Densitometry 
vvas performed to normalize for slight variations in GAPDH bands 
on the Northern blots (Table I), ' thus confirming the above 
interpretation. 
Mast Cell Degranulation Induces Expression of ICAM-l in 
a Skin-Equivalent Model Because the prior studies were all 
performed using monolayer cell cultures, mast cell degranulation ill 
situ was induced in a skin-equivalent model to determine whether 
fibroblasts and/or keratinocytes respond in a similar f.,shion while 
in. a three-dimensional organ culture system. Mast cell degranula-
tion was accomplished by addition of calcium ionophore, as 
described in the ill vitro studies. After overnight incubation, the 
specimens were snap-frozen for immunohistochemical processing 
to assess ICAM-l and VCAM-l expression. Frozen sections were 
stained with anti-ICAM-1 and VCAM-1 MoAbs, as described in 
Materials alld Methods . As shown in Fig lOB, marked up-regulation 
A Fibroblast 8 Fibroblast 
Time: 0 1 4 24 Time: o 1 4 24 
Figure 9. Induction of ICAM-l and VCAM-l mRNA in human 
dermal fibroblasts by MCCM. Confluent human dermal fibroblasts were 
stimulated by MCeM for the time intervals indicated, followed by North-
ern hybridization for ICAM-l (A) and VCAM-l (B) mR.NA (top). R.e-
probing the membrane for GAPDH cDNA (bottom) did not reveal any 
differences over this time in response to MCCM. 
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of ICAM-1 was observed after mast cell degranulation. Intense 
staining was seen within dermal fibroblasts and in groups of 
keratinocytes. Prominent basal epidermal staining was observed in 
both control cultures (i.e ., lacking mast cells and with mast ce lls but 
with no added calcium ionophore A23187; Fig lOA) and experi-
mental cultures (i.e., with mast cells and calcium ionophore 
A23187 added; Fig lOB). Essentially no increase in VCAM-1 
staining was observed after mast cell stimulation . Cultures without 
mast cells revealed no alterations in ICAM-1 or VCAM-1 after 
calcium ionophore treatment. 
DISCUSSION 
Our studies clearly document that mast cell products can stimulate 
T-cell adhesion to fibroblasts . The enhanced T-cell adhesion 
appears to be mediated by up-regulating ICAM-1 and VCAM-1 on 
fibroblasts. Induction of these adhesion molecules was observed 
when mast cells were cocultured with fibroblasts and subsequently 
de granulated. Resting mast cells attach to fibroblasts without 
inducing adhesion molecule expression. However, direct mast cell 
contact was not required, as MCCM was also effective in stinlulat-
ing adhesion molecule expression on fibroblasts . Nonetheless, 
heterotypic coculture experiments demonstrated that a ratio of one 
stimulated mast cell per 100 fibroblasts was sufficient to increase 
expression ofICAM-1 and VCAM-1 significantly. The expression 
resulted from mRNA induction, which was detectable by 1 h. 
Surface protein expression followed within 4 h , peaked at 24 h, and 
decreased slightly toward baseline by 48 h, especially VCAM-1 
expression. Our studies also indicated that ICAM-1 induction 
results from TNF-Oi release by mast ce LIs. Induction ofVCAM-1 is 
more complex and other mediators are presumably involved, 
although TNF-Oi is nonetheless an important contributing factor 
(Fig 8). It is conceivable that cofactor(s) are re leased from the mast 
cells that synergize with TNF- Oi or in some manner amplifY its 
effect. This remains to be defined further in future studies, espe-
cially those using human mast-ce ll- derived products. 
In the evolution of a local inflammatory reaction , circulating 
leukocytes transmigrate endothel ial cell barriers into the extravas-
cular space and accumulate by mechanisms that remain to be 
elucidated fully. The retention of leukocytes in tissue compart-
ments is partly regul ated by integrins on trafficking leukocytes 
binding to subendothelial matrix substances (i.e., cell-matrix inter-
actions), and partly by interactions of surface adhesion molecules on 
cells (such as fibroblasts and epithelial cells) residing within ex-
travascular tissue (i.e. , cell-cell interactions). We speculated that 
degranulating mast cells might release products that stimulate 
cell-cell interactions by inducing adhesion molecule expression. 
Previous data £i'om our laboratory, as well as others, have suggested 
that degranulating mast cells up-regulates endothelial cell surface 
molecules , including E-selectin, ICAM-1, and VCAM-1 [4,14,15). 
The capacity of mast cell s to modulate adhesion molecules on 
extravascular cells was initially suggested by loffreda e/ al [16) by 
demonstrating redistribution of 016 integrin on basal cell keratino-
cytes and up-regulation of 0i6{31 and 0i6{34 integrins on Langerhans 
cells after mast cell degranulation. 
It is widely appreciated that adhesion molecule expression is 
regulated by cytokines [17 ,18), including TNF- O', IL-1 , and IL-4 
[9) . Because mast cells are capable of synthesizing a number of 
cytokines, including TNF- O', IL-1, IL-4, transforming growth 
factor-{3, and lL-6 [19], it seemed plausible that mast-cell-derived 
cytokines were largely responsible for ICAM-1 and VCAM-l 
expression on fibroblasts. Our studies confirmed tllis to a certain 
degree. Neutralizing antibody to TNF-O' essentially abrogated 
up-regulation of ICAM-l. However, VCAM-l expression was 
only partially suppressed, suggesting that other mast cell products 
were also important in VCAM-1 induction. These studies must be 
interpreted with caution, however, because crossed-species of cells 
were required and murine IL-1{3 or IL-4, for example, may not bi.nd 
effectively to human cells. Nonetheless, direct incubation of fibro-
blasts with histamine or heparin failed to show significant effects. 
Further studies wi ll be required to defme any other active sub-
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Table I. Densitometry of Northern Hybridization Blots 
0 0 Units 
o h h 4 h 24 h 
ICAM- 1 mRNA 917 1506 3146 2010 
ICAM- 1/GAPDH 0.1 23 0.384 0.738 0.339 
VCAM- l mR.N A 0 3373 9352 8152 
VCAM- lIGA PDH 0 0.245 0.65 1 0.587 
stan ce(s) that mast ce lls secrete th at regulate fi broblast adhesive-
ness. T he fulding that T NF-a was important ill these studies is 
con sis tent with previous reports using ti ssue explants ex vi"o, in 
w hi c h degranul ated mast cells up-regulated E- selec tin dermal 
microvascular endothelial cell expression [14,20]. In the dermis, 
mast cells appea r to store T N F- a and serve as a maj or repository fo r 
trus potent cytokine [20]. T NF-a, regardless of its source, also 
serves to pro long the survival of inflammatory cells, thus delaying 
programmed cell death [21] . T herefore, mast-ce ll- derived m edia-
to r s , such as T N F-a, induce inflammatory responses by multiple 
pa thvvays: stimulating tran smigra tion " ill ac6va tion of endothelial 
cells, promotin g leukocyte retention by up-regulating fi broblas t 
ad hesiveness, and prolongin g the survival of inflammatory cells at 
perivascular sites. 
We used a skin-equivalent o rgan culture system to assess 
ICAM- l and VCAM -l expression after mast ce ll degranulation, as 
our previous exp erience wi th skin explants indicated intense stain-
ing a lo ng the microvasculature precluding exam ination of extravas-
cular expression . U sing the skin-equiva lent o rgan cul ture sys tem , 
we vvere able to monito r adhesion m olecule expression in the 
absen ce of endothelial cells and associated vascular structures. In 
trus system , ICA M-l express ion was markedly up-regulated by 
mast cells, displ ayed within the epidermis as well as on individual 
fibro blas ts. VC AM-l expression was not detected after mas t ce ll 
stilnula tion , suggesting several poss ibili ties. Conceivably, VCAM-l 
regulation diffe rs w hen fi broblas ts are placed in three-dimensional 
matrices rather than cul tured as monolayers on plastic. T he three-
dimensional derm al matrix m ay not permi t fi'ee diffusion of mast-
cell- derived factors, thus preven6ng the responsible mediato r fi'om 
, reachin g target fibroblasts. Further studies are warranted to inves-
tigate these possibili ties and to confi rm this potentially important 
observation. In separate studies using human fo reskin s in w hich 
mast ce lls were stimulated ill silll , we have observed similar 
find ings, indicating more prominent ICAM- l than VCAM-1 ex-
pressio n . 
Alth o ugh n o t the main focus of our study, the up-regulation of 
keratlllOcyte adhesion m olecules w ithin the epidermis of this skin 
culture system was unexpected and sugges ts yet another mecha-
nism fo r lymphocyte retention at an inflammatory site [22]. Cyto-
kines such as T N F-a are known to up-regulate keratinocyte 
ICAM- l expression ill Vi /I'D [23]. T he ro le of m as t cells in stimu-
lating epidermal ce lls, how ever, has received minim al attention in 
the past. 
In summary, our experullental results sugges t a potentialmech-
anism by w hich m ast cells facilitate an inflammatory reaction, as 
observed in studies using m as t-cell-deficient animals. In immune-
complex-mediated peri toniti s, the absence of m ast cells grea tly 
dam pened the intensity of n eutrophil extravasa tion [24] , similar to 
tha t o bserved with a m odel of cutan eous acute inflammation [25] . 
In these studies, the mechanism s underlying the requirement for 
mas t cells were not probed o ther than to suggest a role fo r T NF-a. 
, Our studies indica te that mast ce ll products act on microvascular 
end o thelial cells [4] as well as extravascular fibroblasts to incite and 
sustain an inflammatory response. In this regard, it is inte resting that 
, Heard et al [26] performed ultrastructural analyses and noted mast 
cells o ften intertwined w ith fibroblasts, occasionally associated with 
lymph ocytes under normal conditions. In alle rgic conditions, in-
creased expression of adhesion m olecules ill situ has been well 
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A 
F ig u re 10. Photomicrog r aph o f skin equiv ale n t stained fo r ICAM- 1 
expression. Mast ce ll s were cocul tured w ith derma l fibroblasts in the 
o rganotypic cu lture at a ratio of 1 :4 . Calcium ionophore (500 ng/ml) was 
added to the skin equi valent conta ining mast ce lls (B) and in the absence of 
m ast cells as control (A) . Degranulation of m ast cell s induced marked 
up- regulation of ICA M-1 within derm al fibro blasts and in gro ups of 
kcratinocytes (B). Bal'. 240 f..Lm . 
documented [27,28]. In fac t, these observations have provided a 
mechanistic fi'amework for considering therapeutic in terven tion 
using MoAbs to specific adhesion m olecul es [29]. Future studies 
w ill provide a better understanding of the precise role that mast 
cells play in inflammatory processes. 
T"is work /lias sllpported by ji llltiillg ji'O/lI tile Depm1111 cII I oj Vel era liS Al]'airs 
Medical Researc" (BLG), Sclerodenlla Federatioll (BLG), Delmatology FOII/ldatioll 
(HM) , Natio llal Illstitllles oj Hea lt" gram AG 4313948 (RAFC), alld P"ysiciall 
Sciem ist A lllard (for Dell iists) DE00263 GAG). 
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